Biological Psychiatry Confirms of Efficacy and Safety of VNS Therapy for Depression

The September 1, 2005 issue of Biological Psychiatry confirmed the efficacy and safety of vagus nerve stimulation for chronic or recurrent treatment-resistant depression. The U.S. Food and Drug Administration issued its final approval of vagus nerve stimulation as a treatment for depression.

The data from the pivotal clinical trial of vagus nerve stimulation and depression was been on published September 1st, in the prestigious peer-reviewed journal of Biological Psychiatry. There were three articles published in Biological Psychiatryabout VNS Therapy and depression. The articles confirm the association of VNS Therapy with significant antidepressant benefits that are sustained and/or growing over one year for patients with chronic or recurrent treatment-resistant depression. Secondly, the long-term safety of the procedure was confirmed.

"The response and remission and sustained long-term benefits realized by the patients treated with adjunctive VNS Therapy is remarkable, given that participants in the trials were some of the most treatment-resistant, depressed patients ever studied, with at least half having been hospitalized for the disease at least once," commented Dr. A. John Rush, MD, Professor and Vice Chairman for Research, Department of Psychiatry, Betty Jo Hay Chair in Mental Health, Rosewood Corporation Chair in Biomedical Science, University of Texas Southwestern Medical Center, Dallas, TX. "The VNS studies presented in these publications provide substantial evidence of a growing benefit of VNS Therapy over time when other treatments have not worked or have stopped working. This is particularly encouraging given the nature of treatment-resistant depression, a devastating and difficult to treat condition."

The publication of these articles is very important to you because third party payers (private insurance companies, Medicare, etc.) will help facilitate the approval of reimbursement of VNS Therapy for depression. Although reimbursement decisions will continue to be on a case-by-case basis, this is a critical next step which will be viewed very positively by insurance companies, Medicare as well as your psychiatrist.

You can learn more about this remarkable treatment at http://www.VagusNerveStimulator.com There is a free newsletter to keep you up-to-date on the latest developments on this first ever FDA approved long term treatment option for chronic or recurrent depression.

Charles Donovan was a study study subject in the FDA investigational trial of vagus nerve stimulation and chronic depression. He is the author of:

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression and founder of the http://wwww.VagusNerveStimulator.com Web site - which is available on Amazon.com, 1-888-VAGUS-88 and at http://www.vagusnervestimulator.com/book/

---

The Cost of Giving Up

I'm sure at times of deep crisis many of you have considered thoughts of "giving up". What is the cost to you of entertaining such thoughts? Well... Read More

Depression and EPA Fish Oil - Does It Really Work?

It is now no secret that people all over the western world are turning to high grade ethyl EPA omega 3 fish oil to treat a number... Read More

Vagus Nerve Stimulation: What are the Benefits and How Does It Relieve Depression?

Vagus nerve stimulation is more effective than antidepressants and is not related to brain surgery or shock treatments. It is a 60-90 minute out-patient procedure, with robust... Read More

I Love You, I Hate You But Dont Go: Understanding Borderline Personality Disorder

It amazes me that 6-10 million Americans have been diagnosed with this isolating disorder. What's amazing about this is that not much is written about BPD much... Read More

Reclaiming Your Life From Anxiety Symptoms

Only somebody who has lived with anxiety ? as either a sufferer or a carer ? knows how devastating it can be. The affect can be seen... Read More

25% of Americans Suffer From a Mental Illness and do Not Get Adequate Relief From Antidepressants

According to the June 7th issue of the Wall Street Journal, more Americans are seeking treatment for mental illnesses than ever before, but most of them fail... Read More

Neuromodulation Is Now The Mainstream Therapy For Chronic Depression

The cover of the March 7, 2005 issue of Business Week titled REWIRING THE HUMAN BODY, describes how neuromodulation brings new hope to the four million desperate... Read More

10 Simple Coping Strategies When a Family Member Has Clinical Depression

1.Remember that it is an illness:Clinical depression often requires medical supervision as well as professional treatment. Clinical depression is treatable and requires commitment, understanding and patience from... Read More

New Treatment for Chronic Depression

Vagus Nerve Stimulation for Chronic Treatment-Resistant Depression About Vagus Nerve Stimulation VNS is not brain surgery, although it is a treatment that affects the function of the... Read More

Depression

The 'experts' have tried to evaluate me as a sufferer of this but found no such evidence or behavior. The same was true for all other mental... Read More

Depression: Bringing Yourself Down

Sometimes it's hard to see the forest from the trees. Sometimes its hard to see how much you can bring your self down. Recently, my life has... Read More

How to Get Rid of Your Worries: 5 Golden Rules and a Warning

Suresh was a worried person when he came to me . "Sir what if I don't get placement ? I feel that I will fail in the... Read More

5 Surefire Tips to Beat Depression Now

Being lonely is a normal part of our everyday lives... We get sad when we fail in our exams, when we're rejected by the person we love,... Read More

Beating Stress, Anxiety and Depression

Why are these illnesses on the rise? And why do some people become so ill through these illnesses, they can find it hard to function?Well they sure... Read More

Chronic Depression: Disease or Charcter Flaw?

A major survey on depression symptoms from the National Mental Health Association (NMHA), released in july 2001, revealed a dramatic degree of progress in public understanding. Yet... Read More